Escherichia coli sequence type ST131 as an emerging fluoroquinolone- resistant uropathogen among renal transplant recipients

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 546-550

  Johnson, James R ^a,b   Johnston, Brian ^a,b   Clabots, Connie ^a   Kuskowski, Michael A ^a,b   Pendyala, Swaroop ^d   DeBroy, Chitrita ^c   Nowicki, Bogdan ^e   Rice, James ^d,f  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e MEHARRY MEDICAL COLLEGE   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE SEQUENCE; KIDNEY GRAFT; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; UROPATHOGENIC ESCHERICHIA COLI;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTI-BACTERIAL AGENTS; BACTERIOPHAGE PHI X 174; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTYPING; URINARY TRACT INFECTIONS;

EID: 73849102484     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01089-09     Document Type: Article

References (17)

1. Burman, W. J., P. E. Breese, B. E. Murray, K. V. Singh, H. A. Batal, T. D. MacKenzie, J. W. Ogle, M. L. Wilson, R. R. Revers, and P. S. Mehler. 2003. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am. J. Med. 115: 358-364.
2. Cagnacci, S., L. Gualco, E. Debbia, G. C. Schito, and A. Marchese. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
3. Clermont, O., M. Lavollay, S. Vimont, C. Deschamps, C. Forestier, C. Branger, E. Denamur, and G. Arlet. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028.
4. Colgan, R., J. R. Johnson, M. Kuskowski, and K. Gupta. 2008. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 52:846-851.
5. Coque, T. M., Â . Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Cantón, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
6. Johnson, J. R., M. A. Kuskowski, A. Gajewski, D. F. Sahm, and J. A. Karlowsky. 2004. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190:1739-1744.
7. Johnson, J. R., M. A. Kuskowski, K. Owens, A. Gajewski, and P. L. Winokur. 2003. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188:759-768.
8. Johnson, J. R., M. Menard, B. Johnston, M. A. Kuskowski, K. Nichol, and G. G. Zhanel. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob. Agents Chemother. 53:2733-2739.
9. Leflon-Guibout, V., J. Blanco, K. Amaqdouf, A. Mora, L. Guize, and M. H. Nicolas-Chanoine. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46: 3900-3905.
10. Machado, J., F. Grimont, and P. A. Grimont. 2000. Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene. Res. Microbiol. 151:535-546.
11. Manges, A. R., H. Tabor, P. Tellis, C. Vincent, and P.-P. Tellier. 2008. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg. Infect. Dis. 14:1575-1583.
12. Nicolas-Chanoine, M.-H., J. Blanco, V. Leflon-Guibout, R. Demarty, M. P. Alonso, M. M. Caniça, Y.-J. Park, J.-P. Lavigne, J. Pitout, and J. R. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
13. Petrof, E. O., D. N. Schwartz, and J. P. Quinn. 2002. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group (letter). N. Engl. J. Med. 346:535.
14. Ramsey, D. E., W. T. Finch, and A. G. Birtch. 1979. Urinary tract infections in kidney transplant recipients. Arch. Surg. 114:1022-1025.
15. Rice, J. C., T. Peng, Y. F. Kuo, S. Pendyala, L. Simmons, J. Boughton, K. Ishihara, S. Nowicki, and B. J. Nowicki. 2006. Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors. Am. J. Transplant. 6:2375-2383.
16. Rubin, R. H. 1993. Infectious disease complications of renal transplantation. Kidney Int. 44:221-236.
17. Tolkoff-Rubin, N. E., and R. H. Rubin. 1997. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect. Dis. Clin. North Am. 11:707-717.